Welcome to CDC Stacks | Immunochemical detection of the occupational allergen, methylene diphenyl diisocyanate (MDI), in situ - 38048 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Immunochemical detection of the occupational allergen, methylene diphenyl diisocyanate (MDI), in situ
  • Published Date:
    Dec 12 2015
  • Source:
    J Immunol Methods. 429:60-65.


Public Access Version Available on: February 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Pubmed ID:
    26690039
  • Pubmed Central ID:
    PMC4753098
  • Funding:
    OH010438/OH/NIOSH CDC HHS/United States
    OH010494/OH/NIOSH CDC HHS/United States
    R21 OH010438/OH/NIOSH CDC HHS/United States
    R21 OH010494/OH/NIOSH CDC HHS/United States
    R41 ES018021/ES/NIEHS NIH HHS/United States
    R42 ES018021/ES/NIEHS NIH HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Diisocyanate chemicals essential to polyurethane production are a well-recognized cause of occupational asthma. The pathogenesis of diisocyanate-induced asthma, including the pathways by which the chemical is taken up and its distribution in exposed tissue, especially the lung, remains unclear. We developed an antiserum with specificity for methylene diphenyl diisocyanate (MDI) the most abundantly produced and utilized diisocyanate world-wide, and established its ability to detect MDI in situ. Polyclonal MDI-specific IgG was induced by immunizing rabbits with MDI-conjugated to keyhole limpet hemocyanin (KLH) emulsified in complete Freund's adjuvant, followed by two booster injections with incomplete Freund's adjuvant. The antiserum contains IgG that recognize a variety of different MDI conjugated proteins, but not unconjugated or mock exposed proteins by dot blot analysis. The antiserum further demonstrates specificity for proteins conjugated with MDI, but not other commonly used diisocyanates. Immunochemical studies with cytospun airway cells and formalin-fixed paraffin embedded lung tissue sections from mice intranasally exposed to MDI (as reversibly reactive glutathione conjugates, e.g. GSH-MDI) demonstrated the antiserum's ability to detect MDI in tissue samples. The data demonstrate penetration of MDI into the lower airways, localized deposition in the epithelial region surrounding airways, and uptake by alveolar macrophages. The new immunochemical reagent should be useful for further studies delineating the uptake and tissue distribution of MDI, especially as it relates to adverse health effects from exposure.

  • Supporting Files:
    No Additional Files